Table 2 Objective questionnaire scores described in means out of 100
From: Patients acceptance and comprehension to written and verbal consent (PAC–VC)
Consent component | Consent type | |
|---|---|---|
Verbal assent | Written consent | |
Purpose of consent | 91.67 | 100.00 |
Purpose of study | 41.67 | 66.67 |
Duration of study | 45.83 | 25.00 |
Nature of study intervention | 50.00 | 66.67 |
Number of study groups | 50.00 | 75.00 |
Understanding of alternative treatments | 33.33 | 33.33 |
Randomization | 37.50 | 50.00 |
Blindness | 25.00 | 25.00 |
Side effects | 70.83 | 33.33 |
Contacts in case of side effects | 62.50 | 25.00 |
Compensation in case of harm | 58.33 | 75.00 |
Voluntariness of withdraw | 83.33 | 91.67 |
Treatment options if refused to participate | 75.00 | 83.33 |
Benefits of participation | 70.00 | 100.00 |
Financial benefits of participation | 83.33 | 91.67 |
Confidentiality | 83.33 | 83.33 |
Whom to contact for any complaints | 83.33 | 75.00 |
Total Score | 61.47 | 64.71 |